Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeba Aziz

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
The Lancet. Global Health|October 2, 2022
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forwardKristina Jenei, Zeba Aziz, Christopher Booth, et al.
Familial Cancer|August 29, 2009
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30Ophira M Ginsburg, Mohammad R Akbari, Zeba Aziz, et al.
Cancer Research and Treatment|March 11, 2017
Symposium: "Oncology Leadership in Asia"Dong-Young Noh, Jae Kyung Roh, Yeul Hong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancerAngelo Di Leo, Henry L Gomez, Zeba Aziz, et al.
JCO Global Oncology|April 11, 2024
Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing CountryRaheel Iftikhar, Usman Ahmad, Ghulam Haider, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2025
Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian CountriesUday Yanamandra, Celine Raphael, Roopika Peela, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancerHenry L Gomez, Dinesh C Doval, Miguel A Chavez, et al.
Cancer Research|April 3, 2008
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international studyShiyu Zhang, Catherine M Phelan, Phil Zhang, et al.
JCO Global Oncology|June 29, 2021
Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified GuidelineVerna D Vanderpuye, Jean Rene V Clemenceau, Sarah Temin, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
The Lancet. Global Health|October 2, 2022
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forwardKristina Jenei, Zeba Aziz, Christopher Booth, et al.
Familial Cancer|August 29, 2009
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30Ophira M Ginsburg, Mohammad R Akbari, Zeba Aziz, et al.
Cancer Research and Treatment|March 11, 2017
Symposium: "Oncology Leadership in Asia"Dong-Young Noh, Jae Kyung Roh, Yeul Hong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancerAngelo Di Leo, Henry L Gomez, Zeba Aziz, et al.
JCO Global Oncology|April 11, 2024
Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing CountryRaheel Iftikhar, Usman Ahmad, Ghulam Haider, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2025
Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian CountriesUday Yanamandra, Celine Raphael, Roopika Peela, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancerHenry L Gomez, Dinesh C Doval, Miguel A Chavez, et al.
Cancer Research|April 3, 2008
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international studyShiyu Zhang, Catherine M Phelan, Phil Zhang, et al.
JCO Global Oncology|June 29, 2021
Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified GuidelineVerna D Vanderpuye, Jean Rene V Clemenceau, Sarah Temin, et al.
Pageof 5